Log in

4880 CellSource Co., Ltd. TSE · Japan

CellSource Co. (4880) news

CellSource Co., Ltd. is a public biotech or pharmaceutical company listed on TSE under the ticker 4880, recorded under Japan. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest CellSource Co. news

We have not published a story on CellSource Co. yet. When there is news, it will appear here.

Questions about CellSource Co.

What is the ticker symbol of CellSource Co.?

CellSource Co., Ltd. trades under the ticker 4880 on TSE.

Where is CellSource Co. listed?

CellSource Co., Ltd. is listed on TSE.

Which country or territory is CellSource Co. listed under?

Our directory records CellSource Co., Ltd. under Japan.

What does CellSource Co. do?

Our directory classifies CellSource Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of CellSource Co.?

The ISIN recorded for CellSource Co., Ltd. is JP3423580004.

Does aibio.space cover CellSource Co.?

aibio.space lists CellSource Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to CellSource Co.?

Companies in our directory listed in the same country and business area as CellSource Co.: Noile-Immune Biotech, Healios KK, Wakamoto Pharmaceutical Co., Kitazato, JCR Pharmaceuticals Co., Taiko Pharmaceutical Co..

Investor discussion: CellSource Co.

Members talk about CellSource Co. (4880). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TSE:4880 on TradingView.

Listing details

CellSource Co., Ltd. is a public biotech or pharmaceutical company listed on TSE under the ticker 4880, recorded under Japan. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
CellSource Co., Ltd.
Ticker
4880
Listing
TSE
Country or territory
Japan
Business scope
Pharmaceuticals: Major
ISIN
JP3423580004
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.